SCHEMBL1708829

SCHEMBL1708829

CN1CCN(c2ccc(C(=O)OC3COC4C(OC(=O)c5ccc(N6CCN(C(F)(F)F)CC6)cc5)COC34)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 9/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HDAC3 O15379 3/20 0.38
HDAC8 Q9BY41 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SCN1A P35498 1/20 0.38
SCN2A Q99250 1/20 0.38
SCN3A Q9NY46 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709604 0.94 BCHE (0.45) BCHESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL1708821 0.91 BCHE (0.51) BCHENPC1RAB9ALMNATP53
SCHEMBL1708825 0.80 BCHE (0.48) BCHEHDAC3HDAC8MAPTHPGD
SCHEMBL1708823 0.76 BCHE (0.51) BCHE
SCHEMBL1709533 0.76 BCHE (0.45) BCHEALDH1A1MAPT
SCHEMBL1708830 0.75 BCHE (0.52) BCHELMNASMN1; SMN2HDAC3HDAC8
SCHEMBL1708826 0.74 BCHE (0.63) BCHE
SCHEMBL1708824 0.73 BCHE (0.47) BCHELMNASMN1; SMN2MAPT
SCHEMBL1708828 0.72 CYP2C19 (0.50) BCHELMNASMN1; SMN2MEN1KMT2A
SCHEMBL1708831 0.71 BCHE (0.59) BCHEALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8287969-B2 Isosorbide derivatives and liquid crystal displays comprising the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2012-10-16 US disclosed
US-20120086902-A1 ISOSORBIDE DERIVATIVES AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120086902-A1 ISOSORBIDE DERIVATIVES AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME CX3CR1, CBX3, YBX3 BCHE 1786/4885NPC1 1298/4885RAB9A 2699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.